Johnson & Johnson has announced it is recalling batches of its Motrin brand coated pain-reliever caplets from store shelves because testing shows the product “may not dissolve as quickly as intended when nearing their expiration date.” The manufacturer was quick to note the product poses no health risk to consumers, but simply may not provide pain relief in a timely manner.

The recalled product was distributed to retailers in the United States, Puerto Rico, Bahamas, Fiji, Belize, St. Lucia and Jamaica. This is not considered a consumer-level recall, meaning consumers do not have to dispose of or return the product.

This is the latest in a series of product recalls that has plagued J&J during the past two and a half years. Since 2009, the company has recalled prescription and over the counter medications, contact lenses and diabetic test strips, as well as medical devices such as replacement hip joints.

The latest Motrin recalled was manufactured at Johnson & Johnson’s factory in Las Piedras, Puerto Rico. That facility and two others have been under investigation by the U.S. Food and Drug Administration due to ongoing problems with quality controls resulting in potentially dangerous products. J&J’s McNeil Consumer Healthcare facility in Fort Washington, Penn., has been closed since spring of 2010, and is currently being renovated by J&J.

This recall includes about 12 million bottles of Motrin IB 24-count coated caplets, Motrin IB 24-count coated tablets and Motrin IB 24+6 count coated caplets.  The full list of products affected by this recall follows:

Consumers with questions or concerns should contact Johnson & Johnson’s consumer call center at 888-222-6036.